⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for melphalan

Every month we try and update this database with for melphalan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Aza-SAHA-GBM With AutoSCT for Refractory LymphomaNCT01983969
Advanced Cancer...
Lymphoma
Azacitidine
Vorinostat
Gemcitabine
Busulfan
Melphalan
Dexamethasone
Caphosol
Glutamine
Pyridoxine
Rituximab
15 Years - 65 YearsM.D. Anderson Cancer Center
Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT03691376
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Sensit...
Platinum-Sensit...
Platinum-Sensit...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Fall...
Refractory Ovar...
Refractory Prim...
Aldesleukin
Autologous NY-E...
Cellular Therap...
Melphalan
18 Years - Roswell Park Cancer Institute
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple MyelomaNCT02043860
Multiple Myelom...
Total Marrow Ir...
Autologous Tran...
Melphalan
Filgrastim (G-C...
18 Years - 75 YearsUniversity of Illinois at Chicago
Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaNCT00907036
Lymphoma
alemtuzumab
donor lymphocyt...
cyclosporine
fludarabine pho...
melphalan
allogeneic hema...
16 Years - 65 YearsNational Cancer Institute (NCI)
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin LymphomaNCT01476839
Recurrent Adult...
basiliximab
carmustine
etoposide
cytarabine
melphalan
pharmacological...
laboratory biom...
autologous hema...
yttrium Y 90-la...
18 Years - 70 YearsCity of Hope Medical Center
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantNCT02333162
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Recurrent Hemat...
Fludarabine Pho...
Melphalan
Intensity-Modul...
Total Marrow Ir...
Allogeneic Hema...
Peripheral Bloo...
Allogeneic Bone...
Tacrolimus
Mycophenolate M...
Laboratory Biom...
18 Years - 75 YearsUniversity of Chicago
Carfilzomib and Stem Cell Transplant for Plasma Cell MyelomaNCT01658904
Multiple Myelom...
Leukemia, Plasm...
Carfilzomib
Melphalan
Filgrastim
18 Years - 75 YearsNational Institutes of Health Clinical Center (CC)
Intra-arterial Chemotherapy(Chemosurgery) for RetinoblastomaNCT00901238
Retinoblastoma
Intra-arterial ...
1 Month - Weill Medical College of Cornell University
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.NCT02909036
Multiple Myelom...
Amyloidosis
Melphalan
Pegfilgrastim
Autologous Hema...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose DexamethasoneNCT01237249
Multiple Myelom...
Melphalan
Prednisone
Velcade
Revlimid
Dexamethasone
65 Years - PETHEMA Foundation
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationNCT01810588
Hematologic Mal...
CliniMACS® CD34...
Fludarabine
Melphalan
anti-thymocyte ...
Rituximab
Total Body Irra...
Mycophenolate M...
Tacrolimus
18 Years - Weill Medical College of Cornell University
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic CholangiocarcinomaNCT02415036
Hepatocellular ...
Intrahepatic Ch...
Delcath Hepatic...
Melphalan
18 Years - Delcath Systems Inc.
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell TumorsNCT00936936
Testicular Canc...
Gemcitabine
Docetaxel
Melphalan
Carboplatin
Mesna
Ifosfamide
Etoposide
Stem Cell Trans...
12 Years - 65 YearsM.D. Anderson Cancer Center
Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaNCT00244946
Lymphoma
therapeutic aut...
carmustine
cytarabine
etoposide
melphalan
peripheral bloo...
15 Years - 70 YearsBarbara Ann Karmanos Cancer Institute
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary MyelofibrosisNCT03118492
Secondary Myelo...
Allogeneic Hema...
Cyclophosphamid...
Fludarabine
Glycosylated Re...
Laboratory Biom...
Melphalan
Mycophenolate M...
Tacrolimus
Total-Body Irra...
18 Years - 65 YearsCity of Hope Medical Center
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerNCT00550784
Fallopian Tube ...
Ovarian Cancer
Peritoneal Cavi...
filgrastim
cisplatin
cyclophosphamid...
melphalan
paclitaxel
topotecan hydro...
TdT-mediated dU...
gene expression...
immunohistochem...
pharmacological...
peripheral bloo...
- 60 YearsCity of Hope Medical Center
Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance TherapyNCT00205764
Multiple Myelom...
Melphalan
19 Years - 70 YearsAustrian Forum Against Cancer
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance LNCT00807599
Multiple Myelom...
Stem cell trans...
lenalidomide an...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple MyelomaNCT00482846
Mucositis
Multiple Myelom...
Palifermin
melphalan
questionnaire a...
autologous peri...
quality-of-life...
18 Years - Barbara Ann Karmanos Cancer Institute
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.NCT00325416
Multiple Myelom...
melphalan
topotecan (TPT)
Autologous Stem...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible DonorNCT01598025
Acute Leukemia
Chronic Leukemi...
Myelodysplastic...
Non-Hodgkins Ly...
total-body irra...
thiotepa
fludarabine pho...
melphalan
anti-thymocyte ...
allogeneic hema...
peripheral bloo...
laboratory biom...
- 19 YearsMemorial Sloan Kettering Cancer Center
MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative ConditioningNCT00564200
Multiple Myelom...
Bortezomib
dexamethasone
Fludarabine
Melphalan
18 Years - 66 YearsPETHEMA Foundation
Nivolumab With Chemotherapy in Refractory MDSNCT03259516
Myelodysplastic...
Nivolumab
Azacitidine
Fludarabine
Cyclophosphamid...
Cytarabine
all trans retin...
Sildenafil
Melphalan
18 Years - 80 YearsSt. Petersburg State Pavlov Medical University
Hematopoietic Stem Cell Transplantation in the Treatment of Infant LeukemiaNCT00357565
Leukemia
Myelodysplastic...
Childhood Acute...
Recurrent Child...
Secondary Acute...
Childhood Acute...
Previously Trea...
Secondary Myelo...
Refractory Anem...
Refractory Anem...
Refractory Anem...
De Novo Myelody...
Childhood Myelo...
filgrastim
busulfan
cyclosporine
fludarabine pho...
melphalan
mycophenolate m...
umbilical cord ...
- 3 YearsMasonic Cancer Center, University of Minnesota
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantNCT00114101
DS Stage I Mult...
DS Stage II Mul...
DS Stage III Mu...
Refractory Mult...
Smoldering Mult...
Autologous Hema...
Laboratory Biom...
Lenalidomide
Melphalan
Peripheral Bloo...
Placebo Adminis...
18 Years - 70 YearsNational Cancer Institute (NCI)
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasNCT00043979
Sarcoma
F-18 Fluorodeox...
therapeutic all...
cyclophosphamid...
cyclosporine
doxorubicin hyd...
etoposide
fludarabine pho...
melphalan
prednisone
sirolimus
tacrolimus
vincristine sul...
peripheral bloo...
Filgrastim
Peripheral Bloo...
5 Years - 35 YearsNational Institutes of Health Clinical Center (CC)
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesNCT00824135
Hematologic Mal...
Clofarabine
Stem Cell Trans...
OKT3
Thiotepa
Melphalan
Mycophenolate m...
Rituximab
G-CSF
- 21 YearsSt. Jude Children's Research Hospital
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple MyelomaNCT02504359
Plasma Cell Leu...
Recurrent Plasm...
Allogeneic Hema...
Carmustine
Cytarabine
Etoposide
Ixazomib Citrat...
Melphalan
Methotrexate
Peripheral Bloo...
Quality-of-Life...
Tacrolimus
18 Years - 65 YearsOHSU Knight Cancer Institute
Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain TumorsNCT01342237
Brain Tumors
HDCT 1(TTC), HD...
- Seoul National University Hospital
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsNCT00303849
Anaplastic Olig...
Anaplastic Olig...
Mixed Glioma
Oligoastrocytom...
Carboplatin
Etoposide
Etoposide Phosp...
Laboratory Biom...
Mannitol
Melphalan
Quality-of-Life...
Sodium Thiosulf...
18 Years - 75 YearsOHSU Knight Cancer Institute
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic LeukemiaNCT00276809
Chronic Lymphoc...
alemtuzumab
filgrastim
carmustine
cyclophosphamid...
cytarabine
dexamethasone
etoposide
fludarabine pho...
melphalan
autologous bone...
peripheral bloo...
radiation thera...
18 Years - 60 YearsGerman CLL Study Group
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerNCT00002680
Breast Cancer
filgrastim
cyclophosphamid...
megestrol aceta...
melphalan
tamoxifen citra...
thiotepa
conventional su...
peripheral bloo...
radiation thera...
18 Years - Yale University
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord TransplantationNCT04395222
Hematologic Mal...
Bone Marrow Tra...
Tocilizumab
Fludarabine
Melphalan
Anti-thymocyte ...
Total Body Irra...
18 Years - Weill Medical College of Cornell University
HD Melphalan and SCT in Patients With IGDD or LCDDNCT00681044
Multiple Myelom...
filgrastim
melphalan
Stem Cell Infus...
18 Years - 120 YearsBoston Medical Center
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisNCT02528877
Acute Myeloid L...
Primary Myelofi...
Primary Myelofi...
Secondary Acute...
Secondary Myelo...
Allogeneic Bone...
Allogeneic Hema...
Fludarabine Pho...
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Ruxolitinib Pho...
Sirolimus
Tacrolimus
18 Years - 75 YearsCity of Hope Medical Center
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)NCT01341262
Multiple Myelom...
Thalidomide
Dexamethasone
Zoledronic acid
Cyclophosphamid...
Melphalan
18 Years - 65 YearsIRCCS Azienda Ospedaliero-Universitaria di Bologna
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorNCT02784054
Intracranial No...
Carboplatin
Etoposide
Cyclophosphamid...
Bleomycin
Thiotepa
Melphalan
Reduced dose ra...
3 Years - 30 YearsSamsung Medical Center
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple MyelomaNCT00504101
Multiple Myelom...
Arsenic trioxid...
Bortezomib
Melphalan
Autologous hema...
18 Years - 70 YearsUniversity of Miami
Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's LymphomaNCT00007852
Lymphoma
rituximab
carmustine
cytarabine
etoposide
melphalan
autologous hema...
19 Years - University of Nebraska
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationNCT04339101
Acute Leukemia
Hematologic and...
Myelodysplastic...
Primary Myelofi...
Secondary Myelo...
Fludarabine
Itacitinib Adip...
Melphalan
Quality-of-Life...
Questionnaire A...
Sirolimus
Tacrolimus
18 Years - 75 YearsCity of Hope Medical Center
Topotecan and Melphalan for RetinoblastomaNCT04799002
Retinoblastoma
Chemotherapy Ef...
Topotecan
Melphalan
- Sun Yat-sen University
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaNCT00567567
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Carboplatin
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Isotretinoin
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Thiotepa
Topotecan Hydro...
Vincristine Sul...
- 30 YearsChildren's Oncology Group
Cellular Therapy With Cord Blood CellsNCT00427557
Multiple Myelom...
Leukemia
Lymphoma
Fludarabine
Melphalan
Umbilical Cord ...
Rituximab
Peripheral Bloo...
- 80 YearsM.D. Anderson Cancer Center
Intra-arterial Chemotherapy(Chemosurgery) for RetinoblastomaNCT00901238
Retinoblastoma
Intra-arterial ...
1 Month - Weill Medical College of Cornell University
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's LymphomaNCT03019640
Mantle Cell Lym...
Recurrent Diffu...
Recurrent Folli...
Recurrent Indol...
Refractory Diff...
Refractory Foll...
Refractory Indo...
Autologous Hema...
Carmustine
Cord Blood-deri...
Cytarabine
Etoposide
Filgrastim
Lenalidomide
Melphalan
Rituximab
15 Years - 70 YearsM.D. Anderson Cancer Center
Nivolumab With Chemotherapy in Refractory MDSNCT03259516
Myelodysplastic...
Nivolumab
Azacitidine
Fludarabine
Cyclophosphamid...
Cytarabine
all trans retin...
Sildenafil
Melphalan
18 Years - 80 YearsSt. Petersburg State Pavlov Medical University
Randomized Double Cord Blood Transplant StudyNCT00067002
Leukemia, Lymph...
Leukemia, Myelo...
Leukemia, Myelo...
Lymphoma, Non-H...
Expanded alloge...
One Unmanipulat...
Rituxan
Melphalan
Thiotepa
Fludarabine
Cyclophosphamid...
Mesna
Total body irra...
1 Month - 80 YearsM.D. Anderson Cancer Center
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantNCT03259503
Recurrent Diffu...
Recurrent T-Cel...
Refractory Diff...
Refractory Hodg...
Refractory T-Ce...
Busulfan
Gemcitabine
Melphalan
Olaparib
Peripheral Bloo...
Pharmacokinetic...
Rituximab
Vorinostat
18 Years - 65 YearsM.D. Anderson Cancer Center
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) AmyloidosisNCT00075608
Multiple Myelom...
Plasma Cell Neo...
filgrastim
melphalan
autologous stem...
stem cell infus...
18 Years - 65 YearsBoston Medical Center
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk NeuroblastomaNCT00539500
Neuroblastoma
Carboplatin
Etoposide
Melphalan
Stem Cell Infus...
ClinicMACS
- M.D. Anderson Cancer Center
Stem Cell Transplantation for Hematological MalignanciesNCT00176839
Leukemia, Lymph...
AML
MDS
Stem Cell Trans...
Busulfan
Cyclophosphamid...
Melphalan
G-CSF
ATG
- 35 YearsMasonic Cancer Center, University of Minnesota
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic MalignanciesNCT00477035
Leukemia
Multiple Myelom...
CIK cells
etoposide
bcnu
cyclophosphamid...
gemcitabine
vinorelbine
melphalan
18 Years - 75 YearsStanford University
CD34+ Enriched Transplants to Treat Myelodysplastic SyndromeNCT05617625
Myelodysplastic...
Graft Vs Host D...
Graft-versus-ho...
Busulfan
Melphalan
Fludarabine
CliniMACS CD34+...
18 Years - 75 YearsBaptist Health South Florida
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL AmyloidosisNCT01383759
Light Chain Dep...
Light Chain and...
Monoclonal Immu...
Amyloidosis
Bortezomib/Dexa...
18 Years - Memorial Sloan Kettering Cancer Center
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorNCT02784054
Intracranial No...
Carboplatin
Etoposide
Cyclophosphamid...
Bleomycin
Thiotepa
Melphalan
Reduced dose ra...
3 Years - 30 YearsSamsung Medical Center
URMC Related Haplo-identical Donor BMTNCT02660281
Hematological D...
Immune Deficien...
Solid Tumors
Myelofibrosis
Multiple Myelom...
Lymphoma
Total Body Irra...
Fludarabine
Pre-Stem Cell I...
Pre-Stem Cell I...
Busulfan
Melphalan
Stem Cell Infus...
Post-Stem Cell ...
Post-Stem Cell ...
Thiotepa
6 Months - 75 YearsUniversity of Rochester
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaNCT00040937
Multiple Myelom...
filgrastim
sargramostim
cyclophosphamid...
dexamethasone
melphalan
prednisone
thalidomide
peripheral bloo...
18 Years - 65 YearsSWOG Cancer Research Network
URMC Related Haplo-identical Donor BMTNCT02660281
Hematological D...
Immune Deficien...
Solid Tumors
Myelofibrosis
Multiple Myelom...
Lymphoma
Total Body Irra...
Fludarabine
Pre-Stem Cell I...
Pre-Stem Cell I...
Busulfan
Melphalan
Stem Cell Infus...
Post-Stem Cell ...
Post-Stem Cell ...
Thiotepa
6 Months - 75 YearsUniversity of Rochester
BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's LymphomaNCT03794167
Non-hodgkin Lym...
Busulfan
Cyclophosphamid...
Etoposide
Melphalan
18 Years - 65 YearsSoonchunhyang University Hospital
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell CancersNCT00003163
Lymphoma
Multiple Myelom...
filgrastim
sargramostim
cyclophosphamid...
melphalan
autologous bone...
peripheral bloo...
radiation thera...
18 Years - National Cancer Institute (NCI)
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple MyelomaNCT00566098
Multiple Myelom...
MILs
Melphalan
PCV13
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell GraftsNCT00968396
Multiple Myelom...
Apheresis
Stem Cell Trans...
Melphalan
18 Years - 75 YearsM.D. Anderson Cancer Center
Haplo Peripheral Blood Sct In GVHD PreventionNCT04473911
GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphom...
Non Hodgkin Lym...
Blood Stem Cell...
Graft Vs Host D...
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
Myeloproliferat...
Chronic Myelomo...
Chemosensitive ...
FLUDARABINE
CYCLOPHOSPHAMID...
TBI
Melphalan
Sirolimus
Mycophenolate m...
RGI-2001
CYCLOPHOSPHAMID...
18 Years - 80 YearsMassachusetts General Hospital
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaNCT00602641
Multiple Myelom...
Laboratory Biom...
Lenalidomide
Melphalan
Prednisone
Quality-of-Life...
Thalidomide
18 Years - National Cancer Institute (NCI)
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma PatientsNCT00661544
Multiple Myelom...
Stem Cell Trans...
Arsenic Trioxid...
Melphalan
Ascorbic Acid
- 70 YearsM.D. Anderson Cancer Center
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic LeukemiaNCT01824693
Juvenile Myelom...
Allogeneic Hema...
Busulfan
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Pharmacological...
Tacrolimus
3 Months - 18 YearsChildren's Oncology Group
2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)NCT03003728
Multiple Myelom...
Elotuzumab
Melphalan
Autologous Stem...
Expanded Natura...
ALT-803
18 Years - 75 YearsUniversity of Arkansas
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With NeuroblastomaNCT00410631
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide phosp...
ifosfamide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
vindesine
autologous hema...
conventional su...
peripheral bloo...
iobenguane I 13...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute LeukemiaNCT00008190
Leukemia
aldesleukin
filgrastim
busulfan
cyclophosphamid...
etoposide
melphalan
peripheral bloo...
- National Cancer Institute (NCI)
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic MalignancyNCT01807611
Leukemia
Lymphoma
Total Lymphoid ...
Fludarabine
Cyclophosphamid...
Thiotepa
Melphalan
HPC,A Infusion
TC-NK Infusion
G-CSF
Mesna
CliniMACS
Mycophenolate m...
- 21 YearsSt. Jude Children's Research Hospital
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDSNCT00025662
Graft vs Host D...
Myelodysplastic...
Leukemia
Leukemia, Myelo...
Leukemia, Myelo...
Leukemia, Lymph...
Lymphoma
Lymphoma, Mantl...
Lymphoma, Non-H...
Hodgkin Disease
RFT5-SMPT-dgA
Isolex system
18 Years - 75 YearsNational Institutes of Health Clinical Center (CC)
ASCT With Nivolumab in Patients With Multiple MyelomaNCT03292263
Multiple Myelom...
Melphalan
Nivolumab
Autologous Stem...
18 Years - 70 YearsSt. Petersburg State Pavlov Medical University
Microdose Study of Melphalan, Bortezomib and DexamethasoneNCT02109861
Multiple Myelom...
Melphalan
Bortezomib
Dexamethasone
18 Years - Aalborg University Hospital
Intensive Versus Conventional Treatment in Patients With Primary AmyloidosisNCT00344526
Primary Systemi...
Melphalan
Dexamethasone
Autologous stem...
18 Years - 70 YearsUniversity Hospital, Limoges
Combination Chemotherapy in Treating Patients With LymphomaNCT00002835
Lymphoma
Bleomycin Sulfa...
Filgrastim (G-C...
Recombinant Int...
Carmustine
Cisplatin (CDDP...
Cyclophosphamid...
Cytarabine (ARA...
Etoposide (VP-1...
Idarubicin
Ifosfamide
Leucovorin Calc...
Melphalan
Methotrexate
Methylprednisol...
mitoxantrone hy...
Vincristine Sul...
Peripheral Bloo...
Radiation Thera...
15 Years - 59 YearsM.D. Anderson Cancer Center
Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CRNCT02497404
Leukemia, Eryth...
Myelodysplastic...
5-Azacytidine
Fludarabine
Melphalan
Alemtuzumab
Total Body Irra...
18 Years - Weill Medical College of Cornell University
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic SyndromeNCT03393611
Myelodysplastic...
Leukemia, Myelo...
Leukemia, Relap...
Myelodysplastic...
CPX-351
Fludarabine
Melphalan
Rabbit Anti-Hum...
Haplo-Cord Stem...
18 Years - 89 YearsWeill Medical College of Cornell University
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesNCT01421173
Lymphoma
Vorinostat
Gemcitabine
Busulfan
Melphalan
Stem Cell Infus...
Rituximab
G-CSF
Palifermin
Dexamethasone a...
12 Years - 65 YearsM.D. Anderson Cancer Center
High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentNCT03234335
Multiple Myelom...
Renal Failure
Data collection
66 Years - Centre Hospitalier Universitaire de Saint Etienne
Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaNCT00004165
Multiple Myelom...
filgrastim
melphalan
peripheral bloo...
- Northwestern University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: